Chugai Pharmaceutical Co. Ltd.
CHGCF | OTC
$42.25
+$1.51 (+3.71%)
At close: Oct 30, 2026, 3:40 PM ET
$42.25
$0.00 (+0.01%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 31.26 | 29.73 | 27 | 14.80 | 20.27 | 42.12 |
PEG Ratio | 2.60 | 1.57 | -2.06 | 0.63 | 0.49 | 1.16 |
PS Ratio | 10.78 | 9.84 | 7.91 | 4.40 | 6.14 | 11.49 |
PB Ratio | 6.70 | 6.06 | 5.41 | 3.89 | 5.17 | 9.23 |
P/FCF Ratio | 43.31 | 29.04 | 26.18 | 32.04 | 29.70 | 62.97 |
P/OCF Ratio | 34.83 | 25.73 | 21.44 | 22.69 | 21.96 | 44.11 |
OCF/S Ratio | 30.96 | 38.24 | 36.88 | 19.37 | 27.97 | 26.05 |
Debt / Equity Ratio | n/a | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 3.56 | 4.70 | 3.79 | 2.46 | 2.61 | 2.76 |
Current Ratio | 4.23 | 5.53 | 4.74 | 3.15 | 3.25 | 3.54 |
Asset Turnover | 0.51 | 0.53 | 0.58 | 0.67 | 0.65 | 0.64 |
Interest Coverage | 575.24 | 5.73K | 5.07K | 8.9K | 8.85K | 5.11K |
Return on Equity | 21.42% | 20.37% | 20.02% | 26.29% | 25.50% | 21.91% |
Return on Assets | 17.58% | 17.54% | 16.84% | 20.03% | 19.69% | 17.38% |
Return on Invested Capital | 20.83% | 20.16% | 18.46% | 25.91% | 25.73% | 21.97% |
Dividend Yield | 2.21% | 1.16% | 1.50% | 2.50% | 1.61% | 1.01% |
Payout Ratio | 68.99% | 34.40% | 40.43% | 36.91% | 32.56% | 42.58% |
FCF Payout Ratio | 95.61% | 33.62% | 39.20% | 79.95% | 47.71% | 63.67% |
Gross Profit Margin | 71.09% | 70.97% | 62.36% | 62.15% | 66.04% | 65.03% |
Net Profit Margin | 34.50% | 33.09% | 29.29% | 29.72% | 30.31% | 27.29% |
Pretax Profit Margin | 47.52% | 46.39% | 39.93% | 42.16% | 41.95% | 37.89% |
Operating Profit Margin | 46.92% | 46.46% | 37.40% | 42.38% | 43.38% | 39% |
FCF Margin | 24.90% | 33.89% | 30.20% | 13.72% | 20.68% | 18.25% |
EBITDA Margin | 50.19% | 49.10% | 42.80% | 44.66% | 45.04% | 41.77% |
Add to Watchlist
Select watchlists to add or remove CHGCF